NCT04325243View on ClinicalTrials.gov

Sildenafil Citrate and Intrapartum Fetal Distress

PHASE4CompletedINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

April 30, 2022

Study Completion Date

July 31, 2022

Conditions
Fetal Distress
Interventions
DRUG

Sildenafil 50 mg

50 mg oral Sildenafil tablet

DRUG

Placebo oral tablet

placebo tablets of the same shape, color and size of Sildenafil tablets manufactured in the Department of Pharmaceuticals, Faculty of Pharmacy

Trial Locations (1)

002

Ahmed Abbas, Assiut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04325243 - Sildenafil Citrate and Intrapartum Fetal Distress | Biotech Hunter | Biotech Hunter